These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 830660)

  • 21. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
    Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
    J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental, diurnal and oestrous cycle-dependent changes in the activity of liver enzymes.
    Stenberg A
    J Endocrinol; 1976 Feb; 68(02):265-72. PubMed ID: 943455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro metabolism of [4-14C] androstenedione and [4-14C] testosterone by rabbit placenta.
    Marchut M
    Endocrinol Exp; 1977; 11(2):139-46. PubMed ID: 301822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutrition-endocrine interactions: induction of reciprocal changes in the delta 4-5 alpha-reduction of testosterone and the cytochrome P-450-dependent oxidation of estradiol by dietary macronutrients in man.
    Kappas A; Anderson KE; Conney AH; Pantuck EJ; Fishman J; Bradlow HL
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7646-9. PubMed ID: 6584878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation.
    Sonne J; Døssing M; Poulsen HE; Pilsgaard H; Rasmussen B; Loft S
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):194-6. PubMed ID: 3583468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism.
    Jin Y; Penning TM
    Best Pract Res Clin Endocrinol Metab; 2001 Mar; 15(1):79-94. PubMed ID: 11469812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of cyclophosphamide action on hepatic P-450 expression.
    LeBlanc GA; Waxman DJ
    Cancer Res; 1990 Sep; 50(18):5720-6. PubMed ID: 2118418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antigonadotropic action of testosterone but not 7alpha-methyl-19-nortestosterone is attenuated through the 5alpha-reductase pathway in the castrated male rat pituitary gland.
    Bandivdekar AH; Karp R; Sundaram K; Kumar N
    J Androl; 2000; 21(2):268-75. PubMed ID: 10714822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites.
    Kohler M; Parr MK; Opfermann G; Thevis M; Schlörer N; Marner FJ; Schänzer W
    Steroids; 2007 Mar; 72(3):278-86. PubMed ID: 17207827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of steroid-5alpha-reductases and comparison of their function with 5beta-reductase.
    Langlois VS; Zhang D; Cooke GM; Trudeau VL
    Gen Comp Endocrinol; 2010 May; 166(3):489-97. PubMed ID: 19686747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency.
    Ueki I; Kimura A; Chen HL; Yorifuji T; Mori J; Itoh S; Maruyama K; Ishige T; Takei H; Nittono H; Kurosawa T; Kage M; Matsuishi T
    J Gastroenterol Hepatol; 2009 May; 24(5):776-85. PubMed ID: 19175828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The crystal structure of human Delta4-3-ketosteroid 5beta-reductase defines the functional role of the residues of the catalytic tetrad in the steroid double bond reduction mechanism.
    Faucher F; Cantin L; Luu-The V; Labrie F; Breton R
    Biochemistry; 2008 Aug; 47(32):8261-70. PubMed ID: 18624455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gas chromatography-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria.
    Casals G; Marcos J; Pozo ÓJ; Aguilera P; Herrero C; To-Figueras J
    Clin Biochem; 2013 Jun; 46(9):819-24. PubMed ID: 23499585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease.
    Sassa S; Granick S; Bickers DR; Bradlow HL; Kappas A
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):732-6. PubMed ID: 4522787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing primary from secondary Δ(4) -3-oxosteroid 5β-reductase (SRD5B1, AKR1D1) deficiency by urinary steroid analysis.
    Yanagi T; Mizuochi T; Homma K; Ueki I; Seki Y; Hasegawa T; Takei H; Nittono H; Kurosawa T; Matsuishi T; Kimura A
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):346-51. PubMed ID: 25154774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biotransformation of tirilazad in human: 3. tirilazad A-ring reduction by human liver microsomal 5alpha-reductase type 1 and type 2.
    Wienkers LC; Steenwyk RC; Hauer MJ; Fleishaker JC; Pearson PG
    J Pharmacol Exp Ther; 1998 Nov; 287(2):583-90. PubMed ID: 9808684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of lead on hepatic delta-aminolaevulinic acid synthetase activity in the rat: a model for drug sensitivity in intermittent acute porphyria.
    Maxwell JD; Meyer UA
    Eur J Clin Invest; 1976 Sep; 6(5):373-9. PubMed ID: 976299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic receptor protein for etiochalanolone in chick embryo liver.
    Lane SE; Gidari AS; Levere RD
    J Biol Chem; 1975 Oct; 250(20):8209-13. PubMed ID: 170283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.